Sun Pharma ended at its intra-day high of Rs 1542, stronger by Rs 38 or 2.5% on the BSE.
The stock had opened at Rs 1513 and touched a high of Rs 1505 during the day.
____________________________________________________________________________________
(Updated at 1150am)
Sun Pharmaceutical Industries is up on getting more support from independent advisory firms in its battle to acquire Israeli drug major Taro Pharmaceutical Industries.
The stock opened at Rs 1,513 and soared to a high of Rs 1,524. The scrip is now trading at Rs 1,523, up 1% from its previous close. The counter clocked volumes of 5,373 shares as compared to the two-week dailya verage traded volumes of 20,294 shares on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app